As Liraglutide Launches Loom, UK Braces For Potential Weight-Loss Explosion
BGMA Says GLP-1s Could Behave Unlike Any Other Generic Or Biosimilar Launch
With a first wave of generic weight-loss medicines poised to hit the UK, local off-patent industry association the BGMA says market dynamics could be unlike those of a typical generic or biosimilar launch, with the current level of unmet demand unclear.
